164 related articles for article (PubMed ID: 38577997)
1. The proportion of CD161 on CD56
Zhao P; Yang Y; Song S; Cheng W; Peng C; Chang X; Wu J; Liu C
Immun Inflamm Dis; 2024 Apr; 12(4):e1244. PubMed ID: 38577997
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome.
Zhao L; Nocturne G; Haskett S; Boudaoud S; Lazure T; Le Pajolec C; Mariette X; Mingueneau M; Banerjee D
Rheumatology (Oxford); 2017 Feb; 56(2):303-312. PubMed ID: 27803305
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome.
Li L; He J; Zhu L; Yang Y; Jin Y; Jia R; Liu X; Liu Y; Sun X; Li Z
J Immunol Res; 2015; 2015():307453. PubMed ID: 26436101
[TBL] [Abstract][Full Text] [Related]
4. The Increased Ratio of Blood CD56
Ming B; Wu T; Cai S; Hu P; Tang J; Zheng F; Ye C; Dong L
J Immunol Res; 2020; 2020():7523914. PubMed ID: 32695834
[TBL] [Abstract][Full Text] [Related]
5. Hsa_circ_0008301 as a potential biomarker of disease activity for primary Sjogren's syndrome: Increased expression in peripheral blood of patients with primary Sjogren's syndrome.
Ji J; Zhang X; Ling Y; Tian J; Wang Y; Luo Y; Zhu R; Zhou Y; Zhu T; Wang L; Zhu H
Int Immunopharmacol; 2022 Nov; 112():109231. PubMed ID: 36113315
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of TIGIT on CD14 + monocytes correlates with clinical features and laboratory parameters of patients with primary Sjögren's syndrome.
Zhao P; Peng C; Chang X; Cheng W; Yang Y; Shen Y; Sun C; Feng X; Liu C; Wu J
Clin Rheumatol; 2024 Jan; 43(1):297-306. PubMed ID: 37749409
[TBL] [Abstract][Full Text] [Related]
7. Increased proportion of CD226 + CD14 + monocytes correlates with clinical features and laboratory parameters in patients with primary Sjögren's syndrome.
Zhao P; Cheng W; Liu C; Peng C; Shen Y; Yang Y; Sun C; Chang X; Wu J
Int J Rheum Dis; 2023 Dec; 26(12):2460-2469. PubMed ID: 37792570
[TBL] [Abstract][Full Text] [Related]
8. Elevated Serum Human Epididymis Protein 4 Is Associated With Disease Activity and Systemic Involvements in Primary Sjögren's Syndrome.
Chen J; Sun F; Bao H; Liang L; Zhan M; Yao H; He J; Liu Y
Front Immunol; 2021; 12():670642. PubMed ID: 34248951
[TBL] [Abstract][Full Text] [Related]
9. Alterations of CD8
Li H; Zhou Y; Wang P; Wang Y; Feng Y; Zhang Y; Wu Z
Clin Rheumatol; 2023 May; 42(5):1327-1338. PubMed ID: 36609932
[TBL] [Abstract][Full Text] [Related]
10. Aberrant distribution of CD3+CD56+ NKT-like cells in patients with primary Sjögren's syndrome.
Zhao L; Xu W; Chen Z; Zhang H; Zhang S; Lian C; Sun J; Chen H; Zhang F
Clin Exp Rheumatol; 2021; 39(1):98-104. PubMed ID: 32242817
[TBL] [Abstract][Full Text] [Related]
11. KLRB1 defines an activated phenotype of CD4+ T cells and shows significant upregulation in patients with primary Sjögren's syndrome.
Zhang Z; Bahabayi A; Liu D; Hasimu A; Zhang Y; Guo S; Liu R; Zhang K; Li Q; Xiong Z; Wang P; Liu C
Int Immunopharmacol; 2024 May; 133():112072. PubMed ID: 38636371
[TBL] [Abstract][Full Text] [Related]
12. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.
Andréasson K; Ohlsson B; Mandl T
Arthritis Res Ther; 2016 Jan; 18():9. PubMed ID: 26759247
[TBL] [Abstract][Full Text] [Related]
14. Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS study.
Seror R; Nocturne G; Lazure T; Hendel-Chavez H; Desmoulins F; Belkhir R; Ravaud P; Benbijja M; Poirier-Colame V; Taoufik Y; Mariette X
Arthritis Res Ther; 2015 Sep; 17(1):241. PubMed ID: 26336930
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of clinical features and prognosis in patients with primary Sjögren's syndrome and autoimmune liver disease].
Chen WQ; Dai XN; Yu Y; Wang Q; Liang JY; Ke YN; Yi CH; Lin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):886-891. PubMed ID: 33047724
[TBL] [Abstract][Full Text] [Related]
16. Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome.
Zhao R; Wang Y; Zhou W; Guo J; He M; Li P; Gao J; Gu Z; Dong C
Clin Rheumatol; 2020 Feb; 39(2):483-489. PubMed ID: 31578648
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren's syndrome.
Yoshimoto K; Suzuki K; Takei E; Ikeda Y; Takeuchi T
Arthritis Res Ther; 2020 Jun; 22(1):157. PubMed ID: 32576236
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
19. Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome?
Sudzius G; Mieliauskaite D; Siaurys A; Viliene R; Butrimiene I; Characiejus D; Dumalakiene I
Rheumatol Int; 2014 Feb; 34(2):235-41. PubMed ID: 24166212
[TBL] [Abstract][Full Text] [Related]
20. Elevated CXCL13 in primary Sjögren's syndrome and its correlation with disease activity: a systematic review and meta-analysis.
Zhu T; Pan Z; Zhang N
Clin Rheumatol; 2022 Sep; 41(9):2791-2802. PubMed ID: 35616754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
